Barclays Maintains Equal-Weight on Biomea Fusion, Raises Price Target to $9

Benzinga · 09/27 14:15
Barclays analyst Peter Lawson maintains Biomea Fusion (NASDAQ:BMEA) with a Equal-Weight and raises the price target from $5 to $9.